1. ADHERENT-INVASIVEE. COLI PROMOTE ER STRESS TO SUPPORT IL23R-DRIVEN AGR2-DEPENDENT ILEOCOLITIS. (22nd January 2022) Authors: Viladomiu, Monica; Khounlotham, Manirath; Dogan, Belgin; Lima, Svetlana; Elsaadi, Ahmed; Herzog, Jeremy; Schoenborn, Alexi; Ellermann, Melissa; Liu, Bo; Zhang, Shiying; Gulati, Ajay; Sartor, R Balfour; Simpson, Kenneth; Lipkin, Steve; Longman, Randy Journal: Inflammatory bowel diseases Issue: Volume 28(2022)Supplement 1 Page Start: S56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis. Issue 3 (24th August 2021) Authors: Hassan-Zahraee, Mina; Ye, Zhan; Xi, Li; Baniecki, Mary Lynn; Li, Xingpeng; Hyde, Craig L; Zhang, Jenny; Raha, Nancy; Karlsson, Fridrik; Quan, Jie; Ziemek, Daniel; Neelakantan, Srividya; Lepsy, Christopher; Allegretti, Jessica R; Romatowski, Jacek; Scherl, Ellen J; Klopocka, Maria; Danese, Silvio;... Journal: Inflammatory bowel diseases Issue: Volume 28:Issue 3(2022) Page Start: 434 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis. Issue 3 (2nd March 2022) Authors: Hassan-Zahraee, Mina; Ye, Zhan; Xi, Li; Baniecki, Mary Lynn; Li, Xingpeng; Hyde, Craig L; Zhang, Jenny; Raha, Nancy; Karlsson, Fridrik; Quan, Jie; Ziemek, Daniel; Neelakantan, Srividya; Lepsy, Christopher; Allegretti, Jessica R; Romatowski, Jacek; Scherl, Ellen J; Klopocka, Maria; Danese, Silvio;... Journal: Inflammatory bowel diseases Issue: Volume 28:Issue 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. (February 2022) Authors: Peyrin-Biroulet, Laurent; Hart, Ailsa; Bossuyt, Peter; Long, Millie; Allez, Matthieu; Juillerat, Pascal; Armuzzi, Alessandro; Loftus, Edward V; Ostad-Saffari, Elham; Scalori, Astrid; Oh, Young S; Tole, Swati; Chai, Akiko; Pulley, Jennifer; Lacey, Stuart; Sandborn, William J; Aguilar, Humberto; Ah... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 2(2022) Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study. (January 2022) Authors: Vermeire, Severine; Lakatos, Peter L; Ritter, Timothy; Hanauer, Stephen; Bressler, Brian; Khanna, Reena; Isaacs, Kim; Shah, Saumin; Kadva, Alysha; Tyrrell, Helen; Oh, Young S; Tole, Swati; Chai, Akiko; Pulley, Jennifer; Eden, Christopher; Zhang, Wenhui; Feagan, Brian G; Abraham, Philip; Acir Crip... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 1(2022) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Henoch‐Schonlein Purpura: 2114. (October 2016) Authors: Barraza, Luis; Schneider, Yecheskel; Longman, Randy; Wan, David; Scherl, Ellen J. Journal: American journal of gastroenterology Issue: Volume 111(2016)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. INNATE TL1A SIGNALING PROMOTES INTESTINAL NEUTROPHIL ACTIVATION AND COLITIS ASSOCIATED CANCER. (26th January 2023) Authors: Pires, Silvia; Yang, Wei; Longman, Randy Journal: Inflammatory bowel diseases Issue: Volume 29(2023)Supplement 1 Page Start: S50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. NON-IMMUNE MEDIATED MUSCULOSKELETAL DISEASE IN CROHN'S DISEASE PATIENTS BEING EVALUATED FOR INFLAMMATORY SPONDYLOARTHRITIS - A PILOT STUDY. (22nd January 2022) Authors: Schwartzman, Monica; Longman, Randy; Scherl, Ellen; Schwartzman, Sergio Journal: Inflammatory bowel diseases Issue: Volume 28(2022)Supplement 1 Page Start: S41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. O-006 Expansion of Immunologically-Relevant E. Coli in the Intestinal Microbiota of Patients with IBD-Associated Spondyloarthritis Promotes Mucosal RORgt-Dependent Immunity. (March 2016) Authors: Kivolowitz, Charles; Abdulhamid, Ahmed; Victorio, Daniel; Castellanos, Jim; Simpson, Kenneth; Scherl, Ellen; Longman, Randy Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. O-006 Expansion of Immunologically-Relevant E. Coli in the Intestinal Microbiota of Patients with IBD-Associated Spondyloarthritis Promotes Mucosal RORgt-Dependent Immunity. (March 2016) Authors: Kivolowitz, Charles; Abdulhamid, Ahmed; Victorio, Daniel; Castellanos, Jim; Simpson, Kenneth; Scherl, Ellen; Longman, Randy Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗